Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lily Huang

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Plos One|February 25, 2016
In Vivo Quantitative Microcomputed Tomographic Analysis of Vasculature and Organs in a Normal and Diseased Mouse ModelNanditha Mohan Das, Sarah Hatsell, Kalyan Nannuru, et al.
Cell Death Discovery|July 26, 2024
GLUT1 inhibitor BAY-876 induces apoptosis and enhances anti-cancer effects of bitter receptor agonists in head and neck squamous carcinoma cellsZoey A Miller, Sahil Muthuswami, Arielle Mueller, et al.
Journal of Digestive Diseases|April 12, 2014
Changing trends in the proportions of small (≤ 2 cm) proximal and non-proximal gastric carcinomas treated at a high-volume tertiary medical center in ChinaJiong Shi, Qi Sun, Bi Yun Xu, et al.
Journal of Primary Care & Community Health|November 4, 2022
Key Stakeholder Perspectives of Community Engagement Efforts and the Impact of the Covid-19 PandemicLily Huang, Tiera Cleveland, Kristin Clift, et al.
Acta Neuropsychiatrica|September 3, 2025
Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Opioid Use Disorders: A Systematic ReviewHezekiah C T Au, Pak Ho Lam, Fateen Kabir, et al.
Journal of Medical Education and Curricular Development|July 7, 2025
Prevalence of Second Victim Experiences in a Cohort of Healthcare Learners and the Impact on Their Well-BeingVanessa E Torbenson, Kirsten A Riggan, Cynthia M Stonnington, et al.
Journal of Patient Safety|November 15, 2023
Rapid Expansion of the Healing Emotional Lives of Peers Program During COVID-19: A Second Victim Peer Support Program for Healthcare ProfessionalsEnid Y Rivera-Chiauzzi, Lily Huang, Alayna K Osborne, et al.
Science Translational Medicine|November 25, 2016
Two tissue-resident progenitor lineages drive distinct phenotypes of heterotopic ossificationDevaveena Dey, Jana Bagarova, Sarah J Hatsell, et al.
The Journal of Clinical Investigation|May 5, 2022
Anti-ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1Senem Aykul, Lily Huang, Lili Wang, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 8, 2017
The Expansion of Heterotopic Bone in Fibrodysplasia Ossificans Progressiva Is Activin A-DependentJaymin Upadhyay, LiQin Xie, Lily Huang, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Plos One|February 25, 2016
In Vivo Quantitative Microcomputed Tomographic Analysis of Vasculature and Organs in a Normal and Diseased Mouse ModelNanditha Mohan Das, Sarah Hatsell, Kalyan Nannuru, et al.
Cell Death Discovery|July 26, 2024
GLUT1 inhibitor BAY-876 induces apoptosis and enhances anti-cancer effects of bitter receptor agonists in head and neck squamous carcinoma cellsZoey A Miller, Sahil Muthuswami, Arielle Mueller, et al.
Journal of Digestive Diseases|April 12, 2014
Changing trends in the proportions of small (≤ 2 cm) proximal and non-proximal gastric carcinomas treated at a high-volume tertiary medical center in ChinaJiong Shi, Qi Sun, Bi Yun Xu, et al.
Journal of Primary Care & Community Health|November 4, 2022
Key Stakeholder Perspectives of Community Engagement Efforts and the Impact of the Covid-19 PandemicLily Huang, Tiera Cleveland, Kristin Clift, et al.
Acta Neuropsychiatrica|September 3, 2025
Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Opioid Use Disorders: A Systematic ReviewHezekiah C T Au, Pak Ho Lam, Fateen Kabir, et al.
Journal of Medical Education and Curricular Development|July 7, 2025
Prevalence of Second Victim Experiences in a Cohort of Healthcare Learners and the Impact on Their Well-BeingVanessa E Torbenson, Kirsten A Riggan, Cynthia M Stonnington, et al.
Journal of Patient Safety|November 15, 2023
Rapid Expansion of the Healing Emotional Lives of Peers Program During COVID-19: A Second Victim Peer Support Program for Healthcare ProfessionalsEnid Y Rivera-Chiauzzi, Lily Huang, Alayna K Osborne, et al.
Science Translational Medicine|November 25, 2016
Two tissue-resident progenitor lineages drive distinct phenotypes of heterotopic ossificationDevaveena Dey, Jana Bagarova, Sarah J Hatsell, et al.
The Journal of Clinical Investigation|May 5, 2022
Anti-ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1Senem Aykul, Lily Huang, Lili Wang, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 8, 2017
The Expansion of Heterotopic Bone in Fibrodysplasia Ossificans Progressiva Is Activin A-DependentJaymin Upadhyay, LiQin Xie, Lily Huang, et al.
Pageof 6